Raj Patel, MD
Ophthalmology · Hendersonville, NCNPI 1164715553
Payments from drug & device makers
Across 151 payments — averaging $992.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harrow Eye, LLC$137K
- Regeneron$8K
- Boston Scientific$891
- Abbott$545
- Astellas Pharma US Inc$366
- Genentech USA, Inc.$362
- plus $2K from 19 others
What the payments were for
- Consulting fees$142,12895%
- Travel & lodging$1,8091%
- Food & beverage$5,7804%
- Education$410%
- Entertainment$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harrow Eye, LLC | 17 | $137,219 |
| Regeneron | 17 | $8,274 |
| Boston Scientific | 10 | $891 |
| Abbott | 5 | $545 |
| Astellas Pharma US Inc | 12 | $366 |
| Genentech USA, Inc. | 20 | $362 |
| AbbVie(2 entities) | 18 | $353 |
| Regeneron Healthcare Solutions, Inc. | 13 | $298 |
| Alcon | 5 | $270 |
| Genentech, Inc. | 2 | $185 |
| NEW World Medical,inc. | 1 | $150 |
| Apellis Pharmaceuticals, Inc. | 5 | $126 |
| Dompe US, Inc. | 1 | $118 |
| Sandoz | 3 | $87 |
| Coherus Oncology, Inc. | 3 | $72 |
| Eyepoint US, Inc. | 3 | $67 |
| Novartis | 4 | $65 |
| Astellas Pharma Global Development | 1 | $63 |
| Optos, Inc. | 1 | $58 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $56 |
| Bausch & Lomb Americas Inc. | 3 | $53 |
| Procept Biorobotics Corporation | 1 | $51 |
| Dutch Ophthalmic, USA | 1 | $49 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IHEEZO$136,643
- TRIESENCE$136,304
- EYLEA HD$7,950
- Proclaim Family of SCS IPGs$311
- GENERAL - STENTS$264
- Proclaim IPG$198
- Kahook Dual Blade$150
- Clearpath$150
- Ahmed Glaucoma Valve$150
- Streamline$150
- Hydrus Microstent$147
- Oxervate$118
- VABYSMO$113
- Izervay$105
- GENERAL VASCULAR ACCESS$100
How this compares
$149,815 in reported general payments places this provider in the 90th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 29 | $1,812 |
| Ketorolac Tromethamine | 23 | $621 |
| MoxifloxacinMoxifloxacin Hcl | 21 | $526 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $417 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 29 | $381 |
| Brimonidine Tartrate | 25 | $257 |
| Latanoprost | 16 | $228 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Hendersonville
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Andrew AntoszykCharlotte$4M
- Majda HadziahmetovicDurham$2.4M
- Preeya GuptaRaleigh$2M
- Thomas WilliamsHickory$1.8M
- James HarrisHickory$1.4M
- Rajiv ShahWinston Salem$1.3M
- Patrick KeltyHickory$1.1M
- Julie WoodwardDurham$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.